Covishield

Why AstraZeneca, Oxford 'Covishield' Vaccine A Better Fit Over Pfizer And Moderna Shots In India

India May Get 100 Million Doses of Oxford’s Coronavirus Vaccine 'Covishield' By December

Covid-19 Vaccine Ready For Rollout By Dec, But Subject To Conditions: Serum Institute CEO Adar Poonawalla

Serum Institute Denies Reports Claiming Indians To Get Covid-19 Vaccine Shots In 73 Days

Covid 19: Serum Institute Of India Caps Oxford Vaccine 'Covishield' Ceiling Price At Rs 225/Dose

Human Trials Of Oxford Vaccine 'Covishield' To Begin In India As DCGI Gives Nod To Serum Institute

India Inches Closer Towards Oxford Vaccine, Panel Recommends DCGI To Permit SII For Human Trials

India Readies 5 Sites For Phase 3 Human Trials Of Oxford Covid-19 Vaccine; SII To Start Manufacturing Next Month